NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Receivables

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW) currently reports a receivables of $33K as of December 2025. That compares with $160K in the prior-year period — down 79.9% year over year. Use the charts on this page to explore NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s receivables history and peer comparisons.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s receivables decreased from $160K to $33K — a 79.9% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) reported $33K in receivables as of December 2025. That compares with $160K in the prior-year period — down 79.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $33K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics Ltd - Warrants (09/11/2026), and consider following NRSNW for alerts when major investors trade the stock.